| A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds A Cumashi, NA Ushakova, ME Preobrazhenskaya, A D'Incecco, A Piccoli, ... Glycobiology 17 (5), 541-552, 2007 | 1187 | 2007 |
| Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 … SM Swain, D Miles, SB Kim, YH Im, SA Im, V Semiglazov, E Ciruelos, ... The Lancet Oncology 21 (4), 519-530, 2020 | 591 | 2020 |
| Chronomodulated versus fixed-infusion—rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (Leucovorin) in patients with colorectal cancer … FA Lévi, R Zidani, JM Vannetzel, B Perpoint, C Focan, R Faggiuolo, ... JNCI: Journal of the National Cancer Institute 86 (21), 1608-1617, 1994 | 451 | 1994 |
| Concentrations of galectin-3 in the sera of normal controls and cancer patients I Iurisci, N Tinari, C Natoli, D Angelucci, E Cianchetti, S Iacobelli Clinical cancer research 6 (4), 1389-1393, 2000 | 427 | 2000 |
| Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer PF Innominato, C Focan, T Gorlia, T Moreau, C Garufi, J Waterhouse, ... Cancer research 69 (11), 4700-4707, 2009 | 228 | 2009 |
| Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic … S Giacchetti, G Bjarnason, C Garufi, D Genet, S Iacobelli, M Tampellini, ... Journal of clinical oncology 24 (22), 3562-3569, 2006 | 228 | 2006 |
| 90K (Mac-2 BP) and galectins in tumor progression and metastasis A Grassadonia, N Tinari, I Iurisci, E Piccolo, A Cumashi, P Innominato, ... Glycoconjugate journal 19, 551-556, 2002 | 217 | 2002 |
| Fucans, but Not Fucomannoglucuronans, Determine the Biological Activities of Sulfated Polysaccharides from Laminaria saccharina Brown Seaweed DO Croci, A Cumashi, NA Ushakova, ME Preobrazhenskaya, A Piccoli, ... PLoS One 6 (2), e17283, 2011 | 143 | 2011 |
| Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients A Marchetti, N Tinari, F Buttitta, A Chella, CA Angeletti, R Sacco, F Mucilli, ... Cancer research 62 (9), 2535-2539, 2002 | 142 | 2002 |
| Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer M Zilli, A Grassadonia, N Tinari, A Di Giacobbe, S Gildetti, J Giampietro, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1795 (1), 62-81, 2009 | 103 | 2009 |
| Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients P Querzoli, M Pedriali, R Rinaldi, AR Lombardi, E Biganzoli, P Boracchi, ... Clinical cancer research 12 (22), 6696-6701, 2006 | 103 | 2006 |
| Immunotherapy in endometrial cancer: new scenarios on the horizon C Di Tucci, C Capone, G Galati, V Iacobelli, MC Schiavi, V Di Donato, ... Journal of gynecologic oncology 30 (3), 2019 | 102 | 2019 |
| Biochemistry of cervical mucus: a comparative analysis of the secretion from preovulatory, postovulatory, and pregnancy periods S Iacobelli, N Garcea, C Angeloni Fertility and Sterility 22 (11), 727-734, 1971 | 81 | 1971 |
| Synthetic inhibitors of galectin-1 and-3 selectively modulate homotypic cell aggregation and tumor cell apoptosis IDA Iurisci, A Cumashi, AA Sherman, YE Tsvetkov, N Tinari, E Piccolo, ... Anticancer research 29 (1), 403-410, 2009 | 80 | 2009 |
| Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer G Corda, G Sala, R Lattanzio, M Iezzi, M Sallese, G Fragassi, ... The Journal of pathology 241 (3), 350-361, 2017 | 78 | 2017 |
| LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis E Piccolo, N Tinari, D Semeraro, S Traini, I Fichera, A Cumashi, ... Journal of molecular medicine 91, 83-94, 2013 | 78 | 2013 |
| Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts A Cumashi, N Tinari, C Rossi, R Lattanzio, C Natoli, M Piantelli, ... Cancer letters 270 (2), 229-233, 2008 | 63 | 2008 |
| Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo B Fornarini, C D'Ambrosio, C Natoli, N Tinari, V Silingardi, S Iacobelli Blood, The Journal of the American Society of Hematology 96 (9), 3282-3285, 2000 | 60 | 2000 |
| Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments C Marchetti, F De Felice, A Romito, V Iacobelli, CM Sassu, G Corrado, ... Seminars in Cancer Biology 77, 144-166, 2021 | 59 | 2021 |
| Tyrosine kinase inhibitors C Natoli, B Perrucci, F Perrotti, L Falchi, S Iacobelli Current Cancer Drug Targets 10 (5), 462-483, 2010 | 56 | 2010 |
